ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2021 Insights on the Global Aesthetic Devices Industry - Featuring Aesthetic Medical Device, Aesthetics Point and Allergan Aesthetics Among Others - ResearchAndMarkets.com

January 11, 2022 GMT

DUBLIN--(BUSINESS WIRE)--Jan 11, 2022--

The “Aesthetic Devices - Medical Devices Pipeline Product Landscape, 2021” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive information about the Aesthetic Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants, and penile implants.

ADVERTISEMENT

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Aesthetic Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Aesthetic Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Aesthetic Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

2 Introduction

2.1 Aesthetic Devices Overview

3 Products under Development

3.1 Aesthetic Devices - Pipeline Products by Stage of Development

3.2 Aesthetic Devices - Pipeline Products by Segment

3.3 Aesthetic Devices - Pipeline Products by Territory

ADVERTISEMENT

3.4 Aesthetic Devices - Pipeline Products by Regulatory Path

3.5 Aesthetic Devices - Pipeline Products by Estimated Approval Date

3.6 Aesthetic Devices - Ongoing Clinical Trials

4 Aesthetic Devices - Pipeline Products under Development by Companies

4.1 Aesthetic Devices Companies - Pipeline Products by Stage of Development

4.2 Aesthetic Devices - Pipeline Products by Stage of Development

5 Aesthetic Devices Companies and Product Overview

6 Aesthetic Devices- Recent Developments

7 Appendix

Companies Mentioned

  • Acoustic Inc
  • Advanced Aesthetic Technologies Inc
  • Aeon Astron Corporation
  • Aesthetic Medical Device
  • Aesthetics Point Ltd.
  • Allergan Aesthetics
  • Almirall Ltd
  • Ambicare Health Ltd
  • Apex Medical Device Design LLC
  • Apyx Medical Corp
  • Arula Technologies
  • Bausch Health Companies Inc
  • Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd
  • BellaSeno GmbH
  • Biosculpture Technology, Inc.
  • Bioxis Pharmaceuticals
  • BMG Pharma SpA
  • Bmi Korea Co Ltd
  • Candela Corp
  • CellPraxis
  • Celltrix AB
  • Clearbridge Health Ltd
  • ClearIt LLC
  • Collplant Biotechnologies Ltd
  • Cutera Inc
  • Cytrellis Biosystems Inc
  • Dexlevo Inc
  • Emory University
  • EP Global Communications Inc (Inactive)
  • Erchonia Corp
  • Establishment Labs SA
  • Eternity Healthcare Inc
  • EternoGen Aesthetics LLC
  • Fillmed Laboratoires
  • Florida International University
  • Forticell Bioscience Inc
  • G2GBIO Inc
  • Galderma SA
  • Genzyme Corp
  • Hallura Ltd
  • HansBiomed Co Ltd
  • Histogen Inc
  • Hugel Inc
  • ImpLite Ltd.
  • Innova Medical Design
  • Innovia LLC
  • Jointechlabs Inc
  • Juvenis Ltd
  • Khorionyx SA
  • Lattice Medical
  • LG Chem Ltd
  • LifeCell Corp
  • LifeSprout Inc
  • Lineage Cell Therapeutics Inc
  • ManaMed Inc
  • Medality Medical LLC
  • Medifirst Solutions Inc
  • Medytox Inc
  • Mentor Worldwide LLC
  • Merz Pharma GmbH & Co KgaA
  • Mesoestetic Pharma Group SL
  • Moma Therapeutics Inc
  • N8 Medical LLC
  • NanoVibronix Inc
  • Neosthetic, LLC
  • NivaSonix, LLC
  • Northwestern University
  • Nu Skin International Inc.
  • Oligo Medic Inc
  • Oxtex Ltd
  • PB&B SA
  • PetVivo Holdings Inc
  • Philips Healthcare
  • PhotoDerma SA
  • PhotoMedex Inc
  • PhotoSonix Medical, Inc.
  • Pinnacle Therapeutics
  • Plcoskin
  • PolyNovo Biomaterials Pty Ltd
  • Prayasta 3D Inventions Pvt Ltd
  • PS Advanced Engineering
  • Q-Med AB
  • Recros Medica Inc
  • Samyang Biopharmaceuticals Corp
  • SANUWAVE Health Inc
  • Sebana Medical Ltd
  • Shanghai Haohai Biological Technology Co Ltd
  • Shin Poong Pharm Co Ltd
  • Sienna Biopharmaceuticals Inc
  • Sientra Inc
  • Silk Medical Aesthetics Inc
  • Sinclair Pharma Ltd
  • Slender Medical Ltd.
  • SMSbiotech Inc
  • Sofregen Medical Inc
  • Soliton Inc
  • Southern Illinois University Carbondale
  • SunMax Biotechnology Co Ltd
  • TEI Biosciences Inc
  • Tempo Therapeutics Inc
  • Tensive SRL
  • Teoxane SA
  • Tetratherix Pty Ltd
  • TeVido BioDevices LLC
  • Tissueform Inc
  • University of California Irvine
  • University of California Santa Barbara
  • University of Pittsburgh
  • Uronext LLC
  • Venus Concept Inc
  • Zeltiq Aesthetics Inc
  • Zift Medical LLC

For more information about this report visit https://www.researchandmarkets.com/r/37iqwt

View source version on businesswire.com:https://www.businesswire.com/news/home/20220111006028/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 01/11/2022 01:58 PM/DISC: 01/11/2022 01:58 PM

http://www.businesswire.com/news/home/20220111006028/en